{"url":"https://lda.senate.gov/api/v1/filings/fd66be38-e39e-4f80-8ab7-c2cfe1f57116/","filing_uuid":"fd66be38-e39e-4f80-8ab7-c2cfe1f57116","filing_type":"Q1","filing_type_display":"1st Quarter - Report","filing_year":2010,"filing_period":"first_quarter","filing_period_display":"1st Quarter (Jan 1 - Mar 31)","filing_document_url":"https://lda.senate.gov/filings/public/filing/fd66be38-e39e-4f80-8ab7-c2cfe1f57116/print/","filing_document_content_type":"text/html","income":"17000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Donald \"Dack\" Dalrymple","dt_posted":"2010-04-09T13:30:43.983000-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1926 N Street NW","registrant_address_2":"Third Floor","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20036","registrant":{"id":5073,"url":"https://lda.senate.gov/api/v1/registrants/5073/","house_registrant_id":34019,"name":"DALRYMPLE & ASSOCIATES, LLC","description":"Business Consulting","address_1":"1926 N Street, NW","address_2":"Suite 1","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20036","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"DONALD \"DACK\" DALRYMPLE","contact_telephone":"+1 202-833-1043","dt_updated":"2022-04-06T16:04:33.500584-04:00"},"client":{"id":105001,"url":"https://lda.senate.gov/api/v1/clients/105001/","client_id":113,"name":"PULMATRIX, INC.","general_description":"Develops broad spectrum pharmaceuticals & delivery system targeting respiratory diseases","client_government_entity":false,"client_self_select":false,"state":"MA","state_display":"Massachusetts","country":"US","country_display":"United States of America","ppb_state":"MA","ppb_state_display":"Massachusetts","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2009-01-01"},"lobbying_activities":[{"general_issue_code":"MED","general_issue_code_display":"Medical/Disease Research/Clinical Labs","description":"Appropriations and funding under federal government contracts for development of broad spectrum products and delivery systems for the prevention, prophylaxis, treatment and halting transmission of infectious respiratory diseases.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":46869,"prefix":"mr","prefix_display":"MR.","first_name":"DONALD","nickname":"DACK","middle_name":null,"last_name":"DALRYMPLE","suffix":null,"suffix_display":null},"covered_position":"Principal and Managing Director","new":false}],"government_entities":[{"id":30,"name":"Army, Dept of (Other)"},{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":116,"name":"Defense Advanced Research Projects Agency (DARPA)"},{"id":25,"name":"Defense, Dept of (DOD)"},{"id":236,"name":"Defense Threat Reduction Agency (DTRA)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":5,"name":"Government Accountability Office (GAO)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":139,"name":"Natl Institutes of Health (NIH)"},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}